SCHEMBL31108244

SCHEMBL31108244

COC(=O)[C@@H]1CCN(Cc2ccc(C(=O)Nc3cccc(-c4cccc(NC(=O)c5ccc(C=O)cn5)c4C)c3Cl)nc2)C1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD274 Q9NZQ7 20/20 0.63
▸ PDCD1 Q15116 19/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108331 0.95 PDCD1 (0.62) CD274PDCD1
SCHEMBL20305010 0.90 PDCD1 (0.63) CD274PDCD1
SCHEMBL20293707 0.90 PDCD1 (0.63) CD274PDCD1
SCHEMBL20293705 0.90 PDCD1 (0.63) CD274PDCD1
SCHEMBL31108316 0.88 CD274 (0.61) CD274PDCD1
SCHEMBL31108236 0.84 CD274 (0.64) CD274PDCD1
SCHEMBL31108291 0.84 PDCD1 (0.56) CD274PDCD1
SCHEMBL20293723 0.83 PDCD1 (0.62) CD274PDCD1
SCHEMBL30127738 0.83 PDCD1 (0.62) CD274PDCD1
SCHEMBL20304892 0.83 PDCD1 (0.62) CD274PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694981-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS Aurigene Oncology Limited (IN) 2026-02-18 — — EP disclosed
WO-2024214088-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS AURIGENE ONCOLOGY LIMITED (IN) 2024-10-17 — — WO disclosed
Send feedback